Development of kits for [99m] Tc radiopharmaceuticals for infection imaging : report of a co-ordinated research project 2000-2003
Author(s)
Bibliographic Information
Development of kits for [99m] Tc radiopharmaceuticals for infection imaging : report of a co-ordinated research project 2000-2003
（IAEA-TECDOC, 1414）
International Atomic Energy Agency, 2004
Available at / 1 libraries
-
No Libraries matched.
- Remove all filters.
Note
Includes bibliographic references
IAEA-TECDOC-1414
Description and Table of Contents
Description
Development of Tc-99m labelling strategies can be useful in the preparation of infection imaging agents by laboratories in Member States. With techniques that were developed for the testing of label stability in vitro and in vivo, with the laboratories participating in the project becoming proficient in labelling the chosen molecules with Tc-99m using a variety of techniques, and with in vivo and in vitro quality assurance measurements standardized by all participants and applied, Tc-99m agents were viewed as reliably labelled. Additionally, with the identification of Tc-99m ubiquicidin peptide 29–41 as a radiolabelled agent with potential clinical utility, the project has made a major contribution to nuclear medicine by providing the first convenient Tc-99m labelled `specific’ infection imaging agent.
by "Nielsen BookData"
